In a Q2 earnings conference call, WeightWatchers' CEO Tara Comant said: "Following the May 22 FDA deadline prohibiting outsourcing facilities from compounding semaglutide, we've been working to transition impacted clinical members to alternative medications, albeit these are generally at higher price points and as other telehealth players are continuing to offer compounded GLP-1RAs under the guise of a personalisation exemption." Novo Nordisk ended a partnership with Hims & Hers just weeks after it had been established amid the controversy of continued compounded subscription services
It affects the ATP, one-carbon, redox and purine-metabolism environment that allows these pathways to move efficiently
I have found the ZOE podcast interesting (no financial involvement) And Margaret MCartnetny view in the BMJ see also Weight Loss in Lactation | InfantRisk Center July 2025 please be aware of the risk of pancreatitis GLP-1 receptor agonists: MHRA to study possible side effects after acute pancreatitis cases | The BMJThe BMJ Data from the Medicines and Healthcare Products Regulatory Agency (MHRA) show that hundreds of cases of acute and chronic pancreatitis, including 10 deaths, have been reported in people taking the drugs, which are used to treat weight loss and diabetes by mimicking a natural hormone released after eating, although it is not certain that the drugs are the cause. June 2025 the MHRA recommended that all women taking skinny jabs should use effective contraception
Coefficient of Variance Intra Variation% 10% Inter Variation% 12% Recovery 95-102% Linearity Diluent Ratio Range % 1:2 93-105 1:4 88-106 1:8 86-108 Specificity/Cross-reactivity No significant cross-reactivity or interference between GSSG and analogues was observed
A dedicated outcomes RCT is needed to confirm whether these complementary effects translate into complementary and non-redundant reductions in hard endpoints
